Abrogated expression of DEC1 during oesophageal squamous cell carcinoma progression is age- and family history-related and significantly associated with lymph node metastasis

British Journal of Cancer

Volumn 104, Issue 5, 2011, Pages 841-849

  Wong, V C L ^a   Ko, J M Y ^a   Qi, R Z ^b   Li, P J ^c   Wang, L D ^c   Li, J L ^d   Chan, Y P ^a   Chan, K W ^a   Stanbridge, E J ^e   Lung, M L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^c ZHENGZHOU UNIVERSITY   (China)

^d Yaocun Esophageal Cancer Hospital   (Austria)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cancer progression; deleted in oesophageal cancer 1 (DEC1); oesophageal cancer family history; oesophageal squamous cell carcinoma; subcellular localisation

Indexed keywords

DELETED IN ESOPHAGEAL CANCER I; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FAMILY HISTORY; FEMALE; GENE DELETION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GOLGI COMPLEX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TISSUE MICROARRAY; TUMOR BIOPSY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CYTOPLASM; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FAMILY HEALTH; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; TISSUE ARRAY ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 79952279945     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.25     Document Type: Article

References (26)

1. Abbaszadegan MR, Raziee HR, Ghafarzadegan K, Shakeri MT, Afsharnez-had S, Ghavamnasiry MR (2005) Aberrant p16 methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma. Int J Gastrointest Cancer 36(1): 47-54
2. Adler J, Parmryd I (2010) Quantifying colocalisation by correlation: the Pearson correlation coefficient is superior to the Mander's overlap coefficient. Cytometry A 77(8): 733-742
3. Buccione R, Caldieri G, Ayala I (2009) Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev 28(1-2): 137-149
4. Chattopadhyay I, Phukan R, Singh A, Vasudevan M, Purkayastha J, Hewitt S, Kataki A, Mahanta J, Kapur S, Saxena S (2009) Molecular profiling to identify molecular mechanism in esophageal cancer with familial clustering. Oncol Rep 21(5): 1135-1146
5. De Groot KM (2006) Cancer of the oesophagus-quo vadis? S Afr Med J 96(3): 197-198
6. Guillemin I, Becker M, Ociepka K, Friauf E, Nothwang HG (2005) A subcellular prefractionation protocol for minute amounts of mammalian cell cultures and tissue. Proteomics 5(1): 35-45 (Pubitemid 40189635)
7. Horner MJRL, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK (eds) (2009) SEER Cancer Statistics Review, 1975-2006. External Web Site Icon National Cancer Institute: Bethesda, MD, based on November 2008 SEER data submission, posted to the SEER Web site
8. Hu N, Goldstein AM, Albert PS, Giffen C, Tang ZZ, Ding T, Taylor PR, Emmert-Buck MR (2003) Evidence for a familial esophageal cancer susceptibility gene on chromosome 13. Cancer Epidemiol Biomarkers Prev 12(10): 1112-1115 (Pubitemid 37310273)
9. Hu N, Roth MJ, Polymeropolous M, Tang ZZ, Emmert-Buck MR, Wang QH, Goldstein AM, Feng SS, Dawsey SM, Ding T, Zhuang ZP, Han XY, Ried T, Giffen C, Taylor PR (2000) Identification of novel regions of allelic loss from a genomewide scan of esophageal squamous-cell carcinoma in a high-risk Chinese population. Genes Chromosomes Cancer 27(3): 217-228 (Pubitemid 30067450)
10. Iakoucheva LM, Brown CJ, Lawson JD, Obradovic Z, Dunker AK (2002) Intrinsic disorder in cell-signaling and cancer-associated proteins. J Mol Biol 323(3): 573-584 (Pubitemid 35283681)
11. Ko J, Wong C, Tang C, Lau K, Lung M (2001) Frequent loss of heterozygosity on multiple chromosomes in Chinese esophageal squamous cell carcinomas. Cancer Lett 170(2): 131-138 (Pubitemid 32709912)
12. Leung AC, Wong VC, Yang LC, Chan PL, Daigo Y, Nakamura Y, Qi RZ, Miller LD, Liu ET, Wang LD, Li JL, Law S, Tsao SW, Lung ML (2008) Frequent decreased expression of candidate tumor suppressor gene, DEC1, and its anchorage-independent growth properties and impact on global gene expression in esophageal carcinoma. Int J Cancer 122(3): 587-594 (Pubitemid 350308950)
13. Li J (1982) Epidemiology of esophageal cancer in China. Natl Cancer Inst Monogr 62: 113-120 (Pubitemid 13102228)
14. Mori T, Yanagisawa A, Kato Y, Miura K, Nishihira T, Mori S, Nakamura Y (1994) Accumulation of genetic alterations during esophageal carcino-genesis. Hum Mol Genet 3(11): 1969-1971 (Pubitemid 24341373)
15. Nishiwaki T, Daigo Y, Kawasoe T, Nakamura Y (2000) Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32. Genes Chromosomes Cancer 27(2): 169-176 (Pubitemid 30030315)
16. Preisinger C, Short B, De Corte V, Bruyneel E, Haas A, Kopajtich R, Gettemans J, Barr FA (2004) YSK1 is activated by the Golgi matrix protein GM130 and plays a role in cell migration through its substrate 14-3-3zeta. J Cell Biol 164(7): 1009-1020 (Pubitemid 38429127)
17. Tang J, Wan T, Wong N, Pang E, Lam K, Law S, Chow L, Ma E, Chan L, Wong J, Srivastava G (2001) Establishment and characterization of a new xenograft-derived human esophageal squamous cell carcinoma cell line SLMT-1 of Chinese origin. Cancer Genet Cytogenet 124(1): 36-41 (Pubitemid 32101470)
18. Tsuchiya E, Nakamura Y, Weng S, Nakagawa K, Tsuchiya S, Sugano H, Kitagawa T (1992) Allelotype of non-small cell lung carcinoma- comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res 52(9): 2478-2481
19. Wang LD, Zhou FY, Li XM, Sun LD, Song X, Jin Y, Li JM, Kong GQ, Qi H, Cui J, Zhang LQ, Yang JZ, Li JL, Li XC, Ren JL, Liu ZC, Gao WJ, Yuan L, Wei W, Zhang YR, Wang WP, Sheyhidin I, Li F, Chen BP, Ren SW, Liu B, Li D, Ku JW, Fan ZM, Zhou SL, Guo ZG, Zhao XK, Liu N, Ai YH, Shen FF, Cui WY, Song S, Guo T, Huang J, Yuan C, Wu Y, Yue WB, Feng CW, Li HL, Wang Y, Tian JY, Lu Y, Yuan Y, Zhu WL, Liu M, Fu WJ, Yang X, Wang HJ, Han SL, Chen J, Han M, Wang HY, Zhang P, Dong JC, Xing GL, Wang R, Guo M, Chang ZW, Liu HL, Guo L, Yuan ZQ, Liu H, Lu Q, Yang LQ, Zhu FG, Yang XF, Feng XS, Wang Z, Li Y, Gao SG, Qige Q, Bai LT, Yang WJ, Lei GY, Shen ZY, Chen LQ, Li EM, Xu LY, Wu ZY, Cao WK, Wang JP, Bao ZQ, Chen JL, Ding GC, Zhuang X, Zhou YF, Zheng HF, Zhang Z, Zuo XB, Dong ZM, Fan DM, He X, Wang J, Zhou Q, Zhang QX, Jiao XY, Lian SY, Ji AF, Lu XM, Wang JS, Chang FB, Lu CD, Chen ZG, Miao JJ, Fan ZL, Lin RB, Liu TJ, Wei JC, Kong QP, Lan Y, Fan YJ, Gao FS, Wang TY, Xie D, Chen SQ, Yang WC, Hong JY, Wang L, Qiu SL, Cai ZM, Zhang XJ (2010) Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet 42(9): 759-763
20. Wen D, Wang S, Zhang L, Wei L, Zhou W, Peng Q (2009) Early onset, multiple primary malignancies, and poor prognosis are indicative of an inherited predisposition to esophageal squamous cell carcinoma for the familial as opposed to the sporadic cases-an update on over 14-year survival. Eur J Med Genet 52(6): 381-385
21. Wong VC, Chen H, Ko MY, Chan KW, Chan YP, Law S, Chua D, Kwong DL, Srivastava G, Tang JC, Tsao SW, Zabarovsky ER, Stanbridge EJ, Lung ML (2011) Tumor suppressor Dual-Specificity Phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype. Int J Cancer; doi:10.1002/ijc.25970
22. Wong VC, Chan PL, Bernabeu C, Law S, Wang LD, Li JL, Tsao SW, Srivastava G, Lung ML (2008) Identification of an invasion and tumor-suppressing gene, Endoglin (ENG), silenced by both epigenetic inactivation and allelic loss in esophageal squamous cell carcinoma. Int J Cancer 123(12): 2816-2823
23. Xibib S, Meilan H, Moller H, Evans H, Dixin D, Wenjie D, Jianbang L (2003) Risk factors for oesophageal cancer in Linzhou, China: a case-control study. Asian Pac J Cancer Prev 4(2): 119-124
24. Yang L, Leung AC, Ko JM, Lo PH, Tang JC, Srivastava G, Oshimura M, Stanbridge EJ, Daigo Y, Nakamura Y, Tang CM, Lau KW, Law S, Lung ML (2005) Tumor suppressive role of a 2.4Mb 9q33-q34 critical region and DEC1 in esophageal squamous cell carcinoma. Oncogene 24(4): 697-705 (Pubitemid 40188574)
25. Yuen HF, Chan YP, Chan KK, Chu YY, Wong ML, Law SY, Srivastava G, Wong YC, Wang X, Chan KW (2007) Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma. Br J Cancer 97(10): 1409-1415 (Pubitemid 350114787)
26. Zhang H, Jin Y, Chen X, Jin C, Law S, Tsao SW, Kwong YL (2006) Cytogenetic aberrations in immortalization of esophageal epithelial cells. Cancer Genet Cytogenet 165(1): 25-35 (Pubitemid 43254649)